ARCHIVES

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

This article is from The Cancer Letter archive.

Vol. 11 No. 38 | October 4, 1985

Download PDF Visit The Full Archive

Related Articles

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011